Review Article | Published:

Acute kidney injury: what's the prognosis?

Nature Reviews Nephrology volume 7, pages 209217 (2011) | Download Citation

Abstract

Acute kidney injury (AKI) is common (especially during critical illness), increasing in incidence, and is associated with considerable morbidity and mortality. The Risk, Injury, Failure, Loss, and End-stage renal disease (RIFLE) classification currently provides a standardized estimate of incidence and outcomes from AKI. Despite advances in the understanding of the pathogenesis of human AKI, our ability to assess kidney function is limited and functional impairment poorly correlates with structural injury to the kidneys. Emerging novel biomarkers are, however, likely to further enhance risk stratification, facilitate early diagnosis, enable early enrollment in therapeutic trials, and assess prognosis. Sepsis remains the leading cause of AKI among the critically ill and over the past few years insights into the pathogenesis of AKI in sepsis are beginning to shift attention from renal blood flow to inflammation-mediated organ injury. Emerging evidence suggests that survivors of AKI incur long-term risks for developing chronic kidney disease and end-stage renal disease compared with those without AKI. Despite decades of research, no specific therapy for AKI other than supportive care currently exists and further work is required to better understand the pathogenesis of AKI during critical illness and to develop novel treatments.

Key points

  • Acute kidney injury (AKI) is common and is associated with higher resource utilization and mortality than that of other critical care syndromes

  • Risk, Injury, Failure, Loss, and End-stage renal disease classification is a validated definition of AKI and together with the AKI Network modification is widely accepted

  • Emerging biomarkers may further aid early diagnosis and risk stratification of AKI

  • Current understanding of the pathogenesis and pathophysiology of AKI is poor and treatment is largely supportive

  • AKI increases susceptibility to chronic kidney disease and end-stage renal disease

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294, 813–818 (2005).

  2. 2.

    et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit. Care 10, R73 (2006).

  3. 3.

    et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J. Am. Soc. Nephrol. 18, 1292–1298 (2007).

  4. 4.

    et al. Mechanisms of filtration failure during postischemic injury of the human kidney. A study of the reperfused renal allograft. J. Clin. Invest. 95, 820–831 (1995).

  5. 5.

    et al. Nature of the renal injury following total renal ischemia in man. J. Clin. Invest. 73, 329–341 (1984).

  6. 6.

    , , , & An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit. Care Med. 34, 1913–1917 (2006).

  7. 7.

    & Acute kidney injury in the intensive care unit according to RIFLE. Crit. Care Med. 35, 1837–1843 (2007).

  8. 8.

    , & Early acute kidney injury and sepsis: a multicentre evaluation. Crit. Care 12, R47 (2008).

  9. 9.

    , , & Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol. Dial. Transplant. 25, 1833–1839 (2010).

  10. 10.

    & Difficulties in understanding human “acute tubular necrosis”: limited data and flawed animal models. Kidney Int. 60, 1220–1224 (2001).

  11. 11.

    & Lesions of the kidney in acute renal failure following shock. Lancet 272, 603–607 (1957).

  12. 12.

    Lectures on the Kidney 3–23 (University Extension Division, University of Kansas, Kansas City, 1943).

  13. 13.

    Evolutionary aspects of renal function. Kidney Int. 49, 1539–1542 (1996).

  14. 14.

    , & The morphology of “acute tubular necrosis” in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) 58, 362–376 (1979).

  15. 15.

    , , , & Dissociation of tubular cell detachment and tubular cell death in clinical and experimental “acute tubular necrosis”. Lab. Invest. 64, 546–556 (1991).

  16. 16.

    et al. Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice. Kidney Int. 67, 2159–2167 (2005).

  17. 17.

    & Creatinine kinetics and the definition of acute kidney injury. J. Am. Soc. Nephrol. 20, 672–679 (2009).

  18. 18.

    , , & Developing a consensus classification system for acute renal failure. Curr. Opin. Crit. Care 8, 509–514 (2002).

  19. 19.

    , , , & Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit. Care 8, R204–R212 (2004).

  20. 20.

    et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit. Care 11, R31 (2007).

  21. 21.

    et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int. 77, 527–535 (2010).

  22. 22.

    , & The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int. 73, 538–546 (2008).

  23. 23.

    , , & A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol. Dial. Transplant. 23, 1203–1210 (2008).

  24. 24.

    Acute Kidney Injury—United States Renal Data System 2009 Annual Data Report. United States Renal Data System [online], , (2009).

  25. 25.

    et al. Validity of international classification of diseases, ninth revision, clinical modification codes for acute renal failure. J. Am. Soc. Nephrol. 17, 1688–1694 (2006).

  26. 26.

    , , , & Declining mortality in patients with acute renal failure, 1988 to 2002. J. Am. Soc. Nephrol. 17, 1143–1150 (2006).

  27. 27.

    et al. Acute kidney injury in a Chinese hospitalized population. Blood Purif. 30, 120–126 (2010).

  28. 28.

    & Defining acute kidney injury in database studies: the effects of varying the baseline kidney function assessment period and considering CKD status. Am. J. Kidney Dis. 56, 651–660 (2010).

  29. 29.

    , , , & Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study. Crit. Care Med. 37, 2552–2558 (2009).

  30. 30.

    , , , & Hospital versus community-acquired acute kidney injury in the critically Ill: differences in epidemiology. J. Am. Soc. Nephrol. 20, 355A (2009).

  31. 31.

    Centers for Disease Control and Prevention (CDC). Hospitalization discharge diagnoses for kidney disease–United States, 1980–2005. MMWR Morb. Mortal. Wkly 57, 309–312 (2005).

  32. 32.

    et al. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin. J. Am. Soc. Nephrol. 4, 891–898 (2009).

  33. 33.

    et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J. Am. Soc. Nephrol. 17, 1135–1142 (2006).

  34. 34.

    et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin. J. Am. Soc. Nephrol. 2, 431–439 (2007).

  35. 35.

    et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 26, 915–921 (2000).

  36. 36.

    et al. Pathophysiology of septic acute kidney injury: what do we really know? Crit. Care Med. 36 (Suppl. 4), S198–S203 (2008).

  37. 37.

    , , , & Renal blood flow in experimental septic acute renal failure. Kidney Int. 69, 1996–2002 (2006).

  38. 38.

    , & Experimental ischemia-reperfusion: biases and myths–the proximal vs. distal hypoxic tubular injury debate revisited. Kidney Int. 77, 9–16 (2010).

  39. 39.

    & Difficulties in understanding human “acute tubular necrosis”: limited data and flawed animal models. Kidney Int. 60, 1220–1224 (2001).

  40. 40.

    , , & Pathophysiology of acute kidney injury: a new perspective. Contrib. Nephrol. 165, 39–45 (2010).

  41. 41.

    et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2, 284–291 (2008).

  42. 42.

    , , & Interleukin-6 regulation of transforming growth factor (TGF)-β receptor compartmentalization and turnover enhances TGF-β1 signaling. J. Biol. Chem. 280, 12239–12245 (2005).

  43. 43.

    et al. Early changes in organ function predict eventual survival in severe sepsis. Crit. Care Med. 33, 2194–2201 (2005).

  44. 44.

    et al. Intensity of continuous renal-replacement therapy in critically ill patients. N. Engl. J. Med. 361, 1627–1638 (2009).

  45. 45.

    et al. Intensity of renal support in critically ill patients with acute kidney injury. N. Engl. J. Med. 359, 7–20 (2008).

  46. 46.

    & Dialysis: results of RENAL—what is the optimal CRRT target dose? Nat. Rev. Nephrol. 6, 191–192 (2010).

  47. 47.

    et al. Evaluation and initial management of acute kidney injury. Clin. J. Am. Soc. Nephrol. 3, 962–967 (2008).

  48. 48.

    & RIFLE criteria provide robust assessment of kidney dysfunction and correlate with hospital mortality. Crit. Care Med. 34, 2016–2017 (2006).

  49. 49.

    & Patients are dying of acute renal failure. Crit. Care Med. 30, 2156–2157 (2002).

  50. 50.

    et al. Comparison of two fluid-management strategies in acute lung injury. N. Engl. J. Med. 354, 2564–2575 (2006).

  51. 51.

    et al. Hydrocortisone therapy for patients with septic shock. N. Engl. J. Med. 358, 111–124 (2008).

  52. 52.

    & Why do patients die of acute kidney injury? Acta Clin. Belg. Suppl. 326–331 (2007).

  53. 53.

    et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B. E. S. T. kidney) investigators. Intensive Care Med. 33, 1563–1570 (2007).

  54. 54.

    et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 22, 707–710 (1996).

  55. 55.

    , , , & Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am. J. Kidney Dis. 40, 275–279 (2002).

  56. 56.

    et al. Long-term outcome of acute tubular necrosis: a contribution to its natural history. Kidney Int. 71, 679–686 (2007).

  57. 57.

    , , , & Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch. Intern. Med. 155, 1505–1511 (1995).

  58. 58.

    et al. Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J. Am. Soc. Nephrol. 14, 1022–1030 (2003).

  59. 59.

    et al. Acute kidney injury increases risk of ESRD among elderly. J. Am. Soc. Nephrol. 20, 223–228 (2009).

  60. 60.

    , , , & Outcomes following diagnosis of acute renal failure in, U. S. veterans: focus on acute tubular necrosis. Kidney Int. 76, 1089–1097 (2009).

  61. 61.

    Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton) 15, 419–428 (2010).

  62. 62.

    et al. Cystatin C as a marker of acute kidney injury in the emergency department. Clin. J. Am. Soc. Nephrol. 5, 1745–1754 (2010).

  63. 63.

    Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark. Med. 4, 265–280 (2010).

  64. 64.

    et al. Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit. Care 13, R104 (2009).

  65. 65.

    et al. Using proteomics to identify preprocedural risk factors for contrast induced nephropathy. Proteomics Clin. Appl. 2, 1058–1064 (2008).

  66. 66.

    et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 73, 465–472 (2008).

  67. 67.

    et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 70, 199–203 (2006).

  68. 68.

    , , , & Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery. Clin. J. Am. Soc. Nephrol. 5, 395–401 (2010).

  69. 69.

    Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol. Dial. Transplant. 24, 3265–3268 (2009).

  70. 70.

    & Defining acute kidney injury: what is the most appropriate metric? Nat. Clin. Pract. Nephrol. 4, 208–215 (2008).

  71. 71.

    , , , & Evaluation of kidney oxygen bioavailability in acute renal failure by blood oxygen level dependent magnetic resonance imaging [Chinese]. Zhejiang. Da. Xue. Xue. Bao. Yi. Xue. Ban. 39, 157–162 (2010).

  72. 72.

    et al. The significance of BOLD MRI in differentiation between renal transplant rejection and acute tubular necrosis. Nephrol. Dial. Transplant. 23, 2666–2672 (2008).

  73. 73.

    & Multiphoton imaging techniques in acute kidney injury. Contrib. Nephrol. 165, 46–53 (2010).

  74. 74.

    et al. Sepsis in European intensive care units: results of the SOAP study. Crit. Care Med. 34, 344–353 (2006).

  75. 75.

    , , , & The evolution of acute renal failure, 1956–1988. Q. J. Med. 74, 83–104 (1990).

  76. 76.

    , , & Acute renal failure in intensive care units--causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French study group on acute renal failure. Crit. Care Med. 24, 192–198 (1996).

  77. 77.

    Prognosis of patients with acute renal failure in the intensive-care unit: a tale of two eras. Mayo Clin. Proc. 71, 117–126 (1996).

  78. 78.

    , & Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med. 26, 1824–1831 (2000).

  79. 79.

    , & The Madrid acute renal failure study group. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Kidney Int. 50, 811–818 (1996).

  80. 80.

    , & Outcome of acute kidney injury with different treatment options: long-term follow-up. Clin. J. Am. Soc. Nephrol. 5, 1755–1762 (2010).

Download references

Acknowledgements

This publication was made possible in part by funding from grants R01DK070910 and R01DK083961 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the grant KL2RR024154 from the National Center for Research Resources (NCRR), and components of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. The contents of this Review are solely the responsibility of the authors and do not necessarily represent the official view of NIDDK, NCRR or NIH.

Author information

Affiliations

  1. The Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Center, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, 3350 Terrace Street, Pittsburgh, PA 15261, USA

    • Raghavan Murugan
    •  & John A. Kellum

Authors

  1. Search for Raghavan Murugan in:

  2. Search for John A. Kellum in:

Contributions

R. Murugan and J. A. Kellum contributed equally to the discussions, research, writing, editing, and reviewing of this manuscript.

Competing interests

R. Murugan and J. A. Kellum declare an association with the following company: Baxter (consultant and grant/research support). J. A. Kellum declares associations with the following companies: Alere (consultant), Abbott Laboratories (consultant), Astute Medical (consultant, grant/research support, patent holder/applicant), Gambro (consultant and grant/research support).

Corresponding author

Correspondence to John A. Kellum.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrneph.2011.13

Further reading